MANA RBM - Risk-Based Monitoring

If such a booster ends up being greenlit, one would hope it would at least benefit a high risk group. Otherwise, it begs why an approval without data supporting one?

Analysis: Necessary or Not, Covid Booster Shots Are Probably on the Horizon In today’s pharmaceutical universe, a simple “safe and effective” determination by the Food and Drug Administration to approve a drug can be manipulated to sell products of questionable value. And …

For those looking for some easier explanations regarding vaccinations, the W.H.O. has put together this series to simplify information on the vaccines.

Vaccine efficacy, effectiveness and protection This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.